Are there fewer surgical complications when using particle embolization for a Meningioma?
Preoperative embolization is a procedure used to treat meningiomas, which are common tumors located in the skull. The goal of this treatment is often to reduce blood loss during surgery. Doctors may use different types of materials for this process, such as particles or liquid agents.
What the research says
A systematic review and meta-analysis of 1,827 patients found that using particle embolization resulted in a significantly lower rate of overall operative complications compared to using liquid agents 2. While both methods were evaluated for several factors, including the amount of blood lost during surgery and the occurrence of ischemic events (loss of blood flow), no significant differences were found between particles and liquids regarding those specific outcomes 2.
Other treatments for meningiomas involve different risks. For example, some studies on proton therapy for these tumors reported a pooled complication rate of 16% 3. Additionally, research into radiation techniques has shown that approximately 8.98% of patients with meningiomas may experience symptomatic radiation necrosis (the death of tissue due to radiation) during certain types of treatment 1.
What to ask your doctor
- What are the specific benefits of using particle embolization versus liquid agents for my procedure?
- How does the choice of embolic material affect the risk of complications during surgery?
- What is the expected rate of complications for my specific type of meningioma?
- Are there other treatment methods, such as proton therapy or radiation, that I should consider based on my tumor's location?
This question is drawn from common patient questions about Neurology and answered using cited medical research. We do not provide individualized advice.